First-time mothers who were randomized to receive a smartphone app called Baby2Home for the first year after giving birth reported significantly fewer symptoms of stress, depression, and anxiety, as well as better overall health, compared to first-time mothers who received usual postpartum care. Continue Reading
News
News
SMFM and its members are deeply concerned by recent developments that threaten to further weaken the public health infrastructure clinicians depend on to protect patients—especially pregnant people and their newborns. Continue Reading
The Society for Maternal-Fetal Medicine (SMFM) and the Infectious Diseases Society for Obstetrics and Gynecology (IDSOG) are deeply troubled by the inaccurate and misleading information regarding vaccines and autism recently posted to the Centers for Disease Control and Prevention (CDC) website. Continue Reading
The Society for Maternal-Fetal Medicine (SMFM) is pleased to announce that Jerasimos Ballas, MD, MPH; Catherine S. Eppes, MD, MPH; Moeun Son, MD, MSCI; and Sarahn M. Wheeler, MD, MHSc, have been elected to the SMFM Board. Continue Reading
Prepregnancy counseling, assembling multidisciplinary care teams, and referring to centers with expertise are critical in managing pregnant patients with heart failure to optimize maternal and newborn health outcomes, according to new guidance issued by SMFM. Continue Reading
In response to today’s White House press conference announcement, The Society for Maternal-Fetal Medicine (SMFM) reiterates its recommendation advising both physicians and patients that acetaminophen is an appropriate medication to treat pain and fever during pregnancy. Continue Reading
The Society for Maternal-Fetal Medicine (SMFM), the national organization representing high-risk pregnancy experts, reiterates its recommendation that all pregnant and breastfeeding people receive the COVID-19 vaccine, regardless of trimester. Continue Reading
The Society for Maternal-Fetal Medicine (SMFM) and the Society of OB/GYN Hospitalists (SOGH) are pleased to announce a focused commitment to our partnership that prioritizes the advancement of hospital-based obstetric care across the United States. Continue Reading
The Society for Maternal-Fetal Medicine (SMFM) continues to advise physicians and patients that acetaminophen is an appropriate medication to treat pain and fever during pregnancy. Continue Reading
SMFM strongly supports the work of the U.S. Preventive Services Task Force (USPSTF) and urges HHS Secretary Robert F. Kennedy, Jr., to retain the current members and the integrity of this critical independent, volunteer group of experts. Continue Reading
As experts in high-risk pregnancies, the Society for Maternal-Fetal Medicine (SMFM) and its members are alarmed by the unsubstantiated and inaccurate claims made by FDA panelists concerning maternal depression and the use of SSRI antidepressants during pregnancy. Continue Reading
AAP, ACP, APHA, IDSA, MPHA, SMFM, and a pregnant physician, filed suit in the U.S. District Court for the District of Massachusetts to defend vaccine policy, and to put an end to the Secretary’s assault on science, public health and evidence-based medicine. Continue Reading